litlas
ログインアカウント作成

Flora Peyvandi

1997–2026 年に発表

260
論文数
24,521
被引用数
82
h 指数
228
i10 指数

被引用数

Flora Peyvandi の年別被引用数1989 年: 被引用 3 件1998 年: 被引用 6 件1999 年: 被引用 8 件2000 年: 被引用 12 件2001 年: 被引用 12 件2002 年: 被引用 27 件2003 年: 被引用 13 件2004 年: 被引用 56 件2005 年: 被引用 33 件2006 年: 被引用 40 件2007 年: 被引用 18 件2008 年: 被引用 59 件2009 年: 被引用 84 件2010 年: 被引用 105 件2011 年: 被引用 108 件2012 年: 被引用 118 件2013 年: 被引用 80 件2014 年: 被引用 84 件2015 年: 被引用 66 件2016 年: 被引用 126 件2017 年: 被引用 129 件2018 年: 被引用 69 件2019 年: 被引用 436 件2020 年: 被引用 961 件2021 年: 被引用 980 件2022 年: 被引用 782 件2023 年: 被引用 450 件2024 年: 被引用 937 件2025 年: 被引用 391 件2026 年: 被引用 6 件1990〜1997 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,637 件、この内訳の 20.1%イタリア: 引用元論文 745 件、この内訳の 9.1%イギリス: 引用元論文 698 件、この内訳の 8.5%ドイツ: 引用元論文 503 件、この内訳の 6.2%フランス: 引用元論文 360 件、この内訳の 4.4%オランダ: 引用元論文 337 件、この内訳の 4.1%中国: 引用元論文 326 件、この内訳の 4%カナダ: 引用元論文 324 件、この内訳の 4%スペイン: 引用元論文 227 件、この内訳の 2.8%スイス: 引用元論文 206 件、この内訳の 2.5%ベルギー: 引用元論文 193 件、この内訳の 2.4%日本: 引用元論文 190 件、この内訳の 2.3%
0%20.1%その他 29.6%

機関

分野

  • Medicine71.5%
  • Biochemistry, Genetics and Molecular Biology12.9%
  • Immunology and Microbiology12%
  • Pharmacology, Toxicology and Pharmaceutics0.7%
  • Neuroscience0.6%
  • Health Professions0.4%
  • その他1.9%

トピック

  • COVID-19 Clinical Research Studies7.4%
  • Hemophilia Treatment and Research6.9%
  • Platelet Disorders and Treatments6%
  • Complement system in diseases4.3%
  • Blood Coagulation and Thrombosis Mechanisms4%
  • Long-Term Effects of COVID-193.3%
  • その他68.1%

共著者

全論文

検索で開く
  1. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura

    著者: Marie Scully, Spero R. Cataland, Flora Peyvandi, Paul Coppo, Paul Knöbl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Filip Callewaert, Debjit Biswas, Hilde De Winter, Robert K. Zeldin - New England Journal of Medicine 2019 被引用: 999

  2. Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

    著者: Johnny Mahlangu, Radosław Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng‐Chieh Chou, Margareth C. Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S. Key, Michael Laffan, Amy L. Dunn, Jane Mason, Doris Quon, Emily Symington, Andrew D. Leavitt, Johannes Oldenburg, Hérvè Chambost, Mark T. Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B. Reddy, Joshua Henshaw, Tara M. Robinson, Wing Yen Wong, Steven W. Pipe - New England Journal of Medicine 2023 被引用: 191

  3. Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A

    著者: Robert Klamroth, Gregory M. Hayes, T. A. Andreeva, Keith Gregg, Takashi Suzuki, Ismail Mitha, Brandon M. Hardesty, Midori Shima, Toni Pollock, Patricia Slev, Johannes Oldenburg, Margareth C. Ozelo, Natalie Stieltjes, Sabine‐Marie Castet, Johnny Mahlangu, Flora Peyvandi, Rashid Kazmi, Jean‐François Schved, Andrew D. Leavitt, Michael U. Callaghan, Brigitte Pan‐Petesch, Doris Quon, Jayson Andrews, Alex Trinh, Mingjin Li, Wing Yen Wong - Human Gene Therapy 2022 被引用: 111

  4. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura

    著者: Flora Peyvandi, Marie Scully, Johanna A. Kremer Hovinga, Spero Cataland, Paul Knöbl, Haifeng Wu, Andrea Artoni, John‐Paul Westwood, Magnus Mansouri Taleghani, Bernd Jilma, Filip Callewaert, Hans Ulrichts, Christian Duby, Dominique Tersago - New England Journal of Medicine 2016 被引用: 658

  5. Hemophilic arthropathy: Current knowledge and future perspectives

    著者: Roberta Gualtierotti, Luigi Piero Solimeno, Flora Peyvandi - Journal of Thrombosis and Haemostasis 2021 被引用: 290

  6. Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium

    著者: Diana A. Gorog, Robert F. Storey, Paul A. Gurbel, Udaya S. Tantry, Jeffrey S. Berger, Mark Y. Chan, Daniel Duerschmied, Susan S. Smyth, William A. Parker, Ramzi Ajjan, Gemma Vilahur, Lina Badimón, Jurriën M. ten Berg, Hugo Ten Cate, Flora Peyvandi, Taia T. Wang, Richard C. Becker - Nature Reviews Cardiology 2022 被引用: 295

  7. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

    著者: Flora Peyvandi, Roberta Palla, Marzia Menegatti, Simona Maria Siboni, Susan Halimeh, Britta Faeser, Helen Pergantou, Helen Platokouki, Paul Giangrande, Kathelijne Peerlinck, Tiraje Çelkan, Nihal Özdemir, Christoph Bidlingmaier, J. Ingerslev, Muriel Giansily‐Blaizot, Jean‐François Schved, Ruth Gilmore, Alain Gadisseur, Majda Benedik‐Dolničar, Lidija Kitanovski, Danijela Miković, Khaled M. Musallam, Frits R. Rosendaal - Journal of Thrombosis and Haemostasis 2012 被引用: 498

  8. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura

    著者: X. Long Zheng, Sara K. Vesely, Spero R. Cataland, Paul Coppo, Brian Geldziler, Alfonso Iorio, Masanori Matsumoto, Reem A. Mustafa, Menaka Pai, Gail Rock, Lene Russell, Rawan Tarawneh, Julie Valdes, Flora Peyvandi - Journal of Thrombosis and Haemostasis 2020 被引用: 393

  9. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies

    著者: Marie Scully, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, J. Evan Sadler, Ravi Sarode, Haifeng Wu, Daniel P. Gale, Yoshihiro Fujimura, Vickie McDonald, Flora Peyvandi, I. Scharrer, Agnès Veyradier, John‐Paul Westwood - Journal of Thrombosis and Haemostasis 2016 被引用: 494

  10. The past and future of haemophilia: diagnosis, treatments, and its complications

    著者: Flora Peyvandi, Isabella Garagiola, Guy Young - The Lancet 2016 被引用: 480

  11. Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis

    著者: Mauro Panigada, Nicola Bottino, Paola Tagliabue, Giacomo Grasselli, Cristina Novembrino, Veena Chantarangkul, Antonio Artigas, Flora Peyvandi, Armando Tripodi - Journal of Thrombosis and Haemostasis 2020 被引用: 1,361

  12. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A

    著者: Flora Peyvandi, Pier Mannuccio Mannucci, Isabella Garagiola, Amal El‐Beshlawy, Mohsen Saleh Elalfy, Vijay Ramanan, Peyman Eshghi, Suresh Hanagavadi, Ramabadran Varadarajan, Mehran Karimi, Mamta Manglani, Cecil Ross, Guy Young, Tulika Seth, Shashikant Apte, Dinesh Nayak, Elena Santagostino, Maria Elisa Mancuso, A.C. Sandoval Gonzalez, Johnny Mahlangu, Santiago Bonanad Boix, M. Cerqueira, Nadia P. Ewing, Christoph Male, Tarek Owaidah, V. Soto Arellano, Nathan L. Kobrinsky, Suvankar Majumdar, Rosario Garrido, Anupam Sachdeva, Mindy Simpson, Mathew Thomas, Ezio Zanon, Bülent Antmen, Kaan Kavaklı, Marilyn J. Manco‐Johnson, Mònica Martínez, E. Marzouka, Maria Gabriella Mazzucconi, Daniela Neme, Ángeles Palomo Bravo, Rogelio Paredes Aguilera, A. Prezotti, Klaus Schmitt, Brian M. Wicklund, Bülent Zülfikar, Frits R. Rosendaal - New England Journal of Medicine 2016 被引用: 491

  13. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura

    著者: X. Long Zheng, Sara K. Vesely, Spero R. Cataland, Paul Coppo, Brian Geldziler, Alfonso Iorio, Masanori Matsumoto, Reem A. Mustafa, Menaka Pai, Gail Rock, Lene Russell, Rawan Tarawneh, Julie Valdes, Flora Peyvandi - Journal of Thrombosis and Haemostasis 2020 被引用: 323

  14. Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A

    著者: Bella Madan, Margareth C Ozelo, Priyanka Raheja, Emily Symington, Doris Quon, Andrew D. Leavitt, Steven W. Pipe, Gillian Lowe, Gili Kenet, Mark T. Reding, Jane Mason, Michael Wang, Annette von Drygalski, Robert Klamroth, Susan Shapiro, Hérvè Chambost, Amy L. Dunn, Johannes Oldenburg, Sheng‐Chieh Chou, Flora Peyvandi, Carolyn M Millar, Dane Osmond, Hua Yu, Ebony Dashiell-Aje, Tara M. Robinson, Johnny Mahlangu - Journal of Thrombosis and Haemostasis 2024 被引用: 60

  15. Redefining outcomes in immune TTP: an international working group consensus report

    著者: Adam Cuker, Spero R. Cataland, Paul Coppo, Javier de la Rubia, Kenneth D. Friedman, James N. George, Paul Knoebl, Johanna A. Kremer Hovinga, Bernhard Lämmle, Masanori Matsumoto, Katerina Pavenski, Flora Peyvandi, Kazuya Sakai, Ravi Sarode, Mari R. Thomas, Yoshiaki Tomiyama, Agnès Veyradier, John‐Paul Westwood, Marie Scully - Blood 2021 被引用: 211

  16. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies

    著者: Marie Scully, Beverley J. Hunt, Sylvia Benjamin, Ri Liesner, Peter Rose, Flora Peyvandi, Betty Cheung, Samuel J. Machin - British Journal of Haematology 2012 被引用: 862

  17. Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7): primary analysis of a phase 3b open-label trial

    著者: Steven W. Pipe, Peter W. Collins, Christophe Dhalluin, Gili Kenet, Christophe Schmitt, Muriel Buri, Víctor Jiménez‐Yuste, Flora Peyvandi, Guy Young, Johannes Oldenburg, Maria Elisa Mancuso, Kaan Kavaklı, Anna Kiialainen, Sonia Deb, Markus Niggli, Tiffany Chang, Michaela Lehle, Karin Fijnvandraat - Blood 2023 被引用: 78

  18. Rare bleeding disorders: diagnosis and treatment

    著者: Roberta Palla, Flora Peyvandi, Amy D. Shapiro - Blood 2015 被引用: 329

  19. A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

    著者: Karin P. M. van Galen, Roseline d’Oiron, Paula James, Rezan A. Kadir, Peter A. Kouides, Roshni Kulkarni, Johnny Mahlangu, Maha Othman, Flora Peyvandi, Dawn Rotellini, Rochelle Winikoff, Robert F. Sidonio - Journal of Thrombosis and Haemostasis 2021 被引用: 161

  20. Liver-related aspects of gene therapy for hemophilia: need for collaborations with hepatologists

    著者: Wolfgang Miesbach, Graham R. Foster, Flora Peyvandi - Journal of Thrombosis and Haemostasis 2023 被引用: 24

  21. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants

    著者: Sekar Kathiresan, Kiran Musunuru, Calum A. MacRae, Calum A MacRae, Benjamin F Voight, Sekar Kathiresan, Sekar Kathiresan, Mark J Daly, Joshua M Korn, Steven A McCarroll, Leena Peltonen, Steven A. McCarroll, James Nemesh, Aarti Surti, Candace Guiducci, Kiran Musunuru, Daniel Mirel, Melissa Parkin, Noel Burtt, David Altshuler, James Nemesh, Kiran Musunuru, Candace Guiducci, Diego Ardissino, Pier M Mannucci, Shaun Purcell, Lauren Gianniny, Melissa Parkin, Changchun Xie, Noël P. Burtt, Joel N. Hirschhorn, Peter S Braund, Steven A. McCarroll, Stacey B. Gabriel, Leena Peltonen, Sekar Kathiresan, Anika Grosshennig, Daniel B. Mirel, Muredach P Reilly, Aarti Surti, David M Nathan, William Matthai, Atif Qasim, Mark Daly, David Altshuler, James B Meigs, Calum A. MacRae, Domenico Girelli, Nicola Martinelli, Oliviero Olivieri, Roberto Corrocher, Gordon Williams, Chris C Patterson, David S Siscovick, Stephen M Schwartz, Benjamin F. Voight, David Siscovick, Steven A. McCarroll, Joshua M. Korn, Gavin Lucas, Shaun Purcell, Panos Deloukas, Veikko Salomaa, Diego Ardissino, Olle Melander, Flora Peyvandi, Marta Spreafico, Pier M Mannucci, Pier M Mannucci, Changchun Xie, Sonia Anand, Sonia Anand, James C. Engert, James C. Engert, Peter S. Braund, Nilesh J Samani, Nilesh J Samani, Nilesh J Samani, Pietro Zonzin, Anika Grosshennig, Heribert Schunkert, Heribert Schunkert, Patrick Linsel‐Nitschke, Michael Preuß, Wolfgang Lieb, Jeanette Erdmann, John R Thompson, Benjamin J Wright, Anthony J Balmforth, Stephen G Ball, Alistair S Hall, Andreas Ziegler, William Matthai, Christian Hengstenberg, Atif Qasim, Klaus Stark, H-Erich Wichmann, Stefan Schreiber, Willem Ouwehand, Michael Scholz ほか 23 名 - Nature Genetics 2009 被引用: 1,096

  22. Complement activation in patients with COVID-19: A novel therapeutic target

    著者: Massimo Cugno, Pier Luigi Meroni, Roberta Gualtierotti, Samantha Griffini, Elena Grovetti, Adriana Torri, Mauro Panigada, Stefano Aliberti, Francesco Blasi, Francesco Tedesco, Flora Peyvandi - Journal of Allergy and Clinical Immunology 2020 被引用: 256

  23. Delivery of AAV‐based gene therapy through haemophilia centres—A need for re‐evaluation of infrastructure and comprehensive care: A Joint publication of EAHAD and EHC

    著者: Wolfgang Miesbach, Pratima Chowdary, Michiel Coppens, Daniel P. Hart, Víctor Jiménez‐Yuste, Robert Klamroth, Michael Makris, Declan Noone, Flora Peyvandi - Haemophilia 2021 被引用: 57

  24. Safety and efficacy of long‐term emicizumab prophylaxis in hemophilia A with factor VIII inhibitors: A phase 3b, multicenter, single‐arm study (STASEY)

    著者: Víctor Jiménez‐Yuste, Flora Peyvandi, Robert Klamroth, Giancarlo Castaman, Chandrakala Shanmukhaiah, Savita Rangarajan, Jaime García Chávez, Raúl Martínez‐Fernández, Gili Kenet, Hazaa Alzahrani, Susan Robson, Christophe Schmitt, Anna Kiialainen, Oliver Meier, Margareth C. Ozelo - Research and Practice in Thrombosis and Haemostasis 2022 被引用: 50